A Confirmatory Study for Evaluation of the Treatment by the Celluma3 of Periorbital Wrinkles

Inclusion Criteria: 1. 30-75 years of age 2. Fitzpatrick Skin Color Type I-IV 3. Clinical evidence of mild to moderate facial wrinkles as specified by the Fitzpatrick Classification of Facial Wrinkling (Perioral and Periorbital) for the degree of wrinkling and elastosis. 4. Willingness and ability to comply with the protocol requirements, including returning for follow up visits and abstaining from excluded behaviors for the duration of the study. 5. Willingness and ability to provide written consent for use of photographic record and adherence to photographic procedures (i.e., removal of makeup and jewelry). 6. Willingness and ability to provide written informed consent prior to any study-related procedure. 7. Absence of any of the exclusionary criteria Exclusion Criteria: 1. Subject who is pregnant, nursing, or planning to become pregnant during the course of the study. 2. Subjects who have any history of diabetes. 3. Subjects who, in the preceding 12 months prior to the study start, have: 1. Been exposed to hyaluronic acid, or 2. any other filler, or 3. injection for cosmetic purposes related to the face, or 4. undergone any cosmetic procedure for the face, or 5. had an active cut, wound or infection of the face, or 6. had oral isotretinon. 4. Subjects who, in the preceding six months prior to the study start, have: 1. Had any botulinum toxin ("Botox"), or 2. had ablative skin resurfacing on the glabellar area. 5. Subjects who, in the preceding three months prior to the study start, have: 1. Had retinoid, microdermabrasion or prescription level glycolic acid treatments, or 2. had any compromising procedure in the opinion of any clinical evaluator. 6. Any other diagnosis of any contraindication in the current User Manual.